Changhua Wang

Title: Changhua Wang and His Patent on a Substituted Nitrogen Heterocyclic Compound.

Introduction

Changhua Wang is an inventor based in Chengdu, China, and is associated with Chengdu Mfs Pharma Co., Ltd. His patent work concerns a substituted nitrogen heterocyclic compound and its potential anesthetic effects.

Latest Patents

Wang is credited with 1 patent, titled “Substituted Nitrogen Heterocyclic Compound and Anesthetic Effect Thereof.” The invention describes a compound, along with related forms such as stereoisomers, pharmaceutically acceptable salts, solvates, prodrugs, metabolites, and deuterated derivatives.

According to the patent description, the compounds may have central nervous system inhibitory effects and potential applications in sedation, hypnosis, general anesthesia, and control of status epilepticus. The disclosure also highlights rapid onset and recovery, while reporting anesthetic activity and little inhibitory effect on adrenocortical function. These are stated potential properties of the invention, rather than established clinical outcomes.

Career Highlights

Wang’s listed patent reflects work on compounds intended for possible use in medicines affecting the central nervous system. The patent presents the compound as a potential option for clinical screening and for the development of sedative, hypnotic, anesthetic, or status epilepticus treatments.

Collaborations

Wang’s listed coworker is Jin Liu. The available information identifies their association but does not specify the nature or extent of their collaboration.

Conclusion

Changhua Wang’s patent focuses on a substituted nitrogen heterocyclic compound with proposed applications in anesthesia, sedation, hypnosis, and status epilepticus treatment. It represents his documented contribution to pharmaceutical invention in Chengdu.